These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7922793

  • 21. Treatment of Paget's disease with calcitonin.
    DeRose J, Avramides A, Baker RK, Wallach S.
    Semin Drug Treat; 1972; 2(1):51-5. PubMed ID: 5065517
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of Paget's disease of bone with once a week injections of salmon calcitonin.
    Avramides A, Flores A, Derose J, Wallach S.
    Br Med J; 1975 Sep 13; 3(5984):632. PubMed ID: 1172455
    [No Abstract] [Full Text] [Related]

  • 23. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 13; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of Paget's disease of bone using synthetic salmon calcitonin administered intranasally].
    Reginster JY, Albert A, Franchimont P.
    Rev Med Liege; 1986 Jan 01; 41(1):13-8. PubMed ID: 3952394
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of Paget's disease of bone with salmon calcitonin.
    Manderlier T, Fuss M, Brauman J, Orloff S, Bergans A, Corvilain J.
    Acta Clin Belg; 1976 Jan 01; 31(6):329-38. PubMed ID: 1035459
    [No Abstract] [Full Text] [Related]

  • 26. Future horizons for calcitonin: a U.S. perspective.
    Carstens JH, Feinblatt JD.
    Calcif Tissue Int; 1991 Jan 01; 49 Suppl 2():S2-6. PubMed ID: 1933616
    [Abstract] [Full Text] [Related]

  • 27. Intranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging.
    Clissold SP, Fitton A, Chrisp P.
    Drugs Aging; 1991 Jan 01; 1(5):405-23. PubMed ID: 1794028
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA.
    Am J Med; 1990 Aug 01; 89(2):181-4. PubMed ID: 2382666
    [Abstract] [Full Text] [Related]

  • 29. One year's treatment of Paget's disease of bone by synthetic salmon calcitonin as a nasal spray.
    Reginster JY, Jeugmans-Huynen AM, Albert A, Denis D, Franchimont P.
    J Bone Miner Res; 1988 Jun 01; 3(3):249-52. PubMed ID: 3213619
    [Abstract] [Full Text] [Related]

  • 30. Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.
    Reginster JY, Gennari C, Mautalen C, Deroisy R, Denis D, Lecart MP, Vandalem JL, Collette J, Franchimont P.
    Scand J Rheumatol; 1990 Jun 01; 19(1):83-6. PubMed ID: 2309107
    [No Abstract] [Full Text] [Related]

  • 31. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
    Haddad JG, Caldwell JG.
    J Clin Invest; 1972 Dec 01; 51(12):3133-41. PubMed ID: 4674398
    [Abstract] [Full Text] [Related]

  • 32. Clinical efficacy of salmon calcitonin in Paget's disease of bone.
    Singer FR.
    Calcif Tissue Int; 1991 Dec 01; 49 Suppl 2():S7-8. PubMed ID: 1933617
    [Abstract] [Full Text] [Related]

  • 33. Treatment of Paget's disease of bone.
    Singer FR.
    Postgrad Med; 1975 Mar 01; 57(3):117-20. PubMed ID: 123333
    [No Abstract] [Full Text] [Related]

  • 34. [Salmon calcitonin nasal spray in the treatment of Paget's disease].
    Giustina A, Macca C, Bossoni S, Romanelli G, Zuccato F.
    Recenti Prog Med; 1989 Nov 01; 80(11):599-602. PubMed ID: 2623325
    [Abstract] [Full Text] [Related]

  • 35. [Paget's disease of bone and calcitonin nasal spray].
    Rico H, Hernández ER.
    Med Clin (Barc); 1986 Jun 21; 87(4):169. PubMed ID: 3736239
    [No Abstract] [Full Text] [Related]

  • 36. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G, Franchimont P, Gaspar S, Gysen P, Kanis JA.
    Ann Endocrinol (Paris); 1981 Jun 21; 42(3):265-75. PubMed ID: 7316460
    [Abstract] [Full Text] [Related]

  • 37. New modes of administration of salmon calcitonin in Paget's disease. Nasal spray and suppository.
    Nagant de Deuxchaisnes C, Devogelaer JP, Huaux JP, Dufour JP, Esselinckx W, Engelbeen JP, Stasse P, Hermans P, de Buisseret JP.
    Clin Orthop Relat Res; 1987 Apr 21; (217):56-71. PubMed ID: 3549096
    [Abstract] [Full Text] [Related]

  • 38. Salmon calcitonin: a review of current and future therapeutic indications.
    Chesnut CH, Azria M, Silverman S, Engelhardt M, Olson M, Mindeholm L.
    Osteoporos Int; 2008 Apr 21; 19(4):479-91. PubMed ID: 18071651
    [Abstract] [Full Text] [Related]

  • 39. Cardiac output in Paget's disease: response to long-term salmon calcitonin therapy.
    Woodhouse NJ, Crosbie WA, Mohamedally SM.
    Br Med J; 1975 Dec 20; 4(5998):686. PubMed ID: 1203724
    [No Abstract] [Full Text] [Related]

  • 40. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance.
    Singer FR, Fredericks RS, Minkin C.
    Arthritis Rheum; 1980 Oct 20; 23(10):1148-54. PubMed ID: 7000081
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.